AquaCelle logo with stylized overlapping blue and teal circles and the company name below.

Omega-3

Supercharge Bioavailability

AquaCelle® Omega-3 is specifically designed to enhance bioavailability of DHA+EPA in fish, krill and algal oil.

Scientifically proven and clinically tested in humans, AquaCelle® Omega-3 dramatically improves absorption, while increasing omega-3 uptake by over 600%.

AquaCelle® Omega-3 advantages

  • enhanced bioavailability over x6

  • an option for a smaller dose size

  • clinically proven

  • improved EPA + DHA absorption

  • counteracts unpleasant “fishy” reflux

  • can be included in water-based formulations

  • stable formulation

  • Australian developed and made

  • utilises patent technology

Two transparent glass beakers, one filled with water and the other empty, placed on a black surface against a white background.
Illustration of a human digestive system showing oral intake of fish oil, with a diagram of SEDDS plus fish oil and a graph depicting the effects of fish oil and SEDDS on plasma DHA levels and oral bioavailability over 24 hours. AquaCelle

AquaCelle® Omega-3 improves EPA and DHA bioavailability

This study assessed the ability of a self-emulsifying drug delivery system (SEDDS), AquaCelle®, as an additive to enhance the oral absorption of Omega-3 ethyl esters (EE) in healthy subjects under low-fat diet conditions.

Logo of the Australian Government Department of Industry, Innovation and Science featuring a kangaroo and emu above a shield.

NSW Department of Industry Tech Connections Voucher granted for AquaCelle® Omega study.